Two leaders in blood pressure management, SunTech Medical Inc., a leader in noninvasive blood pressure products and technologies, and AtCor Medical (ASX:ACG) the developer and marketer of the SphygmoCor® system, which noninvasively measures central blood pressures and arterial stiffness, announced today that the companies have formed a strategic alliance aimed at improving blood pressure measurement and overall cardiovascular health assessment and management.
The alliance will bring together SunTech Medical’s expertise in motion-tolerant and other application specific blood pressure measurement technologies and AtCor Medical’s market-leading technology for the noninvasive measurement of central aortic blood pressure. Together, the companies will develop and deliver new blood pressure monitoring products and solutions to benefit patient diagnosis, hypertension management and the global research community.
“We are extremely pleased to form this alliance with AtCor Medical. Their SphygmoCor systems have become the gold standard for measuring central aortic blood pressure and arterial stiffness,” said Dayn McBee, CEO at SunTech Medical. “We are very excited about what the future holds in bringing our two companies and technologies together and cooperating on integrated offerings.”
Duncan Ross, AtCor Medical CEO added, “We regard this alliance as an important step towards developing improved and more comprehensive capabilities to assess cardiovascular disease progression and therapeutic efficacy. SunTech Medical has a strong history of delivering blood pressure monitoring solutions to the market and we’re delighted to bring our capabilities together.”
The announcement of this important strategic alliance builds on the agreement announced in July, 2011 whereby AtCor Medical is the worldwide exclusive distributor of the SunTech Oscar2™ twenty four hour blood pressure monitor to the pharmaceutical clinical trials market.